Vallon Pharmaceuticals, Inc. (VLON) Social Stream
Vallon Pharmaceuticals Inc (VLON) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Vallon Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
Over the past 100 days, VLON's average price target has gone down $0.
VLON reports an average of 125.63% for its upside potential over the past 29 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VLON Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Vallon Pharmaceuticals Inc's number of analysts covering the stock is higher than nearly none of them.
- In terms of how Vallon Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
- Vallon Pharmaceuticals Inc's average analyst price target is greater than 97.06% of stocks in the nano market cap category.
- In the context of Healthcare stocks, Vallon Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 88.16% of them.
In the Pharmaceutical Products industry, UNCY, RNAZ, and PTPI are the three stocks most similar to Vallon Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is VLON a Buy, Hold or Sell? See the POWR Ratings now!